A federal judge denied Florida Blue's request to reconsider Medicare Advantage star ratings linked to Broward County's 2023 flooding, citing CMS's regulatory criteria for public health emergencies.
Medicare phone scams are rising, with fraudsters posing as representatives to steal personal info. Learn how insurance professionals can help protect beneficiaries.
Explore how private equity's rise in U.S. health care consolidation affects hospitals, physician practices, care quality, costs, and regulatory responses.
UnitedHealth Group's 2025 stock decline reflects rising medical costs and DOJ investigations, impacting healthcare sector valuations and Dow index dynamics.
Explore critical regulatory updates and compliance strategies for healthcare providers navigating evolving vaccine policies and Medicare billing rules. Learn from expert legal and clinical insights to manage outbreak risks and optimize revenue cycle operations.
Ohio health providers like Central Ohio Primary Care begin charging fees for certain MyChart messages requiring medical expertise, reflecting broader trends in rising U.S. healthcare spending and telehealth service billing.
Comprehensive update on critical U.S. healthcare and insurance issues including Medicaid policy, rural hospital challenges, Medicare Advantage scrutiny, FDA drug approvals, and public health dynamics.
TD Cowen lowers UnitedHealth stock rating and price target due to increased risk and regulatory issues in Medicare Advantage and Medicaid sectors, amid ongoing criminal investigation. Brokerages maintain an outperform stance with long-term valuation upside noted.
UnitedHealth Group faces a DOJ investigation for possible Medicare fraud, leading to its worst monthly stock slump and raising regulatory and market concerns in the U.S. health insurance sector.
New analysis shows Inflation Reduction Act provisions will reduce Medicare Part D out-of-pocket costs for specialty drugs etanercept, ustekinumab, and ibrutinib, improving affordability for beneficiaries.
